✦ LIBER ✦

Treatment and outcomes of post-transplant lymphoproliferative disease: A single institution study

✍ Scribed by Francis K. Buadi; Meyer R. Heyman; Christopher D. Gocke; Aaron P. Rapoport; Roger Hakimian; Stephen T. Bartlett; Clarence Sarkodee-Adoo

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 187 KB
Volume: 82
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.20795

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subcutaneous implantation of human post-

Subcutaneous implantation of human post-transplant lymphoproliferative disease lesions in SCID mice

✍ Parmjeet S. Randhawa; Beatta Pietrzak; Michael A. Nalesnik; Anthony Jake Demetri 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

The tumorigenic potential of six post-transplant B-cell lymphoproliferative disease (PTLD) lesions was evaluated in SCID mice. Three animals developed local subcutaneous B cell tumours, two of which contained Epstein-Barr virus (EBV) DNA. Two animals developed CD3 positive thymic neoplasms, and one

Melanoma of unknown primary site : Prese

Melanoma of unknown primary site : Presentation, treatment, and prognosis—a single institution study

✍ Kevin K. Anbari; Lynn M. Schuchter; Louis P. Bucky; Rosemarie Mick; Marie Synnes 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## RESULTS. Sixty-five percent of the patients presented with lymph node metastasis for the University of Pennsylvania only, 28% presented with visceral lesions, and 8% presented with subcutaneous ## Pigmented Lesion Study Group nodules. The prevalence of dysplastic nevi was 22.5%. The overall

Simultaneous radiochemotherapy in the tr

Simultaneous radiochemotherapy in the treatment of inoperable, locally advanced head and neck cancers. A single-institution study

✍ Giovanni Franchin; Carlo Gobitti; Emilio Minatel; Antonino de Paoli; Gianni Boz; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

Background. Patients with advanced, inoperable head and neck cancers have cure rates of approximately 10-15%. In these patients, concomitant chemoradiotherapy seems to improve local control and survival. 5-Fluorouracil(5-FU) administered by continuous infusion and cisplatin plus concomitant conventi